ADVERTISEMENT
LIVE DESK·Global markets desk·Last updated 14s ago
ADVERTISEMENT

Latest

BlackRock Raises Stake in Public Policy Holding to 4.06%
EquitiesArticle

BlackRock Raises Stake in Public Policy Holding to 4.06%

Asset manager BlackRock increased its position in Public Policy Holding Co. to 4.06% from 3.42%, with the move disclosed under UK Financial Conduct Authority rules.

Priya Anand · 26 Sept 2026
AGF Management reports $74B AUM growth but misses Q3 EPS
ForexArticle

AGF Management reports $74B AUM growth but misses Q3 EPS

Toronto-based asset manager AGF saw year-over-year asset growth of 31% despite a 15% EPS shortfall and a 7% share price decline.

Sophie Laurent · 26 Sept 2026
BlackRock Discloses 3.42% Stake in Public Policy Holding
EquitiesArticle

BlackRock Discloses 3.42% Stake in Public Policy Holding

Asset manager reports major-holding notification to UK regulators after crossing the threshold, holding over 1.04 million voting rights in the Wilmington-based company.

Priya Anand · 26 Sept 2026
AGF Q3 Earnings Miss as Assets Surge 31% to $74.2 Billion
EarningsArticle

AGF Q3 Earnings Miss as Assets Surge 31% to $74.2 Billion

Toronto-based AGF Management reported a third-quarter profit miss and weak revenue as fee compression weighed on results, though AUM jumped 31% driven by alternatives growth.

Priya Anand · 26 Sept 2026
Cambridge Cognition Chair Buys 19,000 Shares at 27.4p
EquitiesArticle

Cambridge Cognition Chair Buys 19,000 Shares at 27.4p

Non-executive chair Nick Rodgers acquires 19,000 shares in Cambridge Cognition Holdings plc at a price of 27.4p per share, raising his stake to 0.18% of issued share capital.

Priya Anand · 26 Sept 2026
Citi sees EU-China trade policy as key for Volkswagen’s next year
EquitiesArticle

Citi sees EU-China trade policy as key for Volkswagen’s next year

Citi maintains a Buy rating and €100 target on Volkswagen, saying the stock’s direction over the next 12 months will depend heavily on whether the European Union imposes trade protections against Chinese competition.

Priya Anand · 26 Sept 2026
Airtel Money listing signals London's fintech potential, but drought persists
CompaniesArticle

Airtel Money listing signals London's fintech potential, but drought persists

Airtel Money's £6bn-£7bn listing marks a welcome addition to London's stock market, but the listings drought continues, with Visma still a top target.

Helena Vásquez · 26 Sept 2026
ArcPoint Launches Global AI-Driven Platform for Modern Investors
CompaniesArticle

ArcPoint Launches Global AI-Driven Platform for Modern Investors

The fintech firm expands its institutional intelligence platform, targeting institutional and retail investors with automated market insights and human expertise.

Helena Vásquez · 26 Sept 2026
Fonix Reports FY26 Growth, Expands Europe with Double-Digit Returns
EquitiesArticle

Fonix Reports FY26 Growth, Expands Europe with Double-Digit Returns

Fonix plc delivered year-over-year growth across revenue, gross profit, and adjusted EBITDA in FY26, while expanding into new European markets and enhancing its payment and media services infrastructure.

Priya Anand · 26 Sept 2026
ADVERTISEMENT
Novara — A Smarter Way to Access Global Markets
UCB Highlights Five Growth Drivers, Pipeline Advances at J.P. Morgan Call
CompaniesArticle

UCB Highlights Five Growth Drivers, Pipeline Advances at J.P. Morgan Call

Belgian biotech UCB outlined pipeline milestones and commercial progress for BIMZELX, citing four acquisitions this year and strong early data from galvokimig in atopic dermatitis.

Helena Vásquez · 26 Sept 2026
Vor Biopharma outlines telitacicept's dual path at Stifel forum
CompaniesArticle

Vor Biopharma outlines telitacicept's dual path at Stifel forum

Vor Biopharma's telitacicept shows strongest-ever results in myasthenia gravis as the company charts a two-indication trajectory against rivals.

Helena Vásquez · 26 Sept 2026
Equillium’s Oral AhR Modulator EQ504 Advances in Phase I Trials for IBD and Lung Diseases
EquitiesArticle

Equillium’s Oral AhR Modulator EQ504 Advances in Phase I Trials for IBD and Lung Diseases

Equillium’s lead mucosal immunology candidate, EQ504, is poised for first-in-human dosing in Q4 2026, targeting inflammatory bowel disease and respiratory conditions via targeted colonic and inhaled delivery.

Priya Anand · 26 Sept 2026
Bitwise Launches First Lighter ETP on Deutsche Börse Xetra
CryptoArticle

Bitwise Launches First Lighter ETP on Deutsche Börse Xetra

Bitwise has issued the first exchange-traded product tracking LIT, the token of decentralized derivatives platform Lighter, which competes with Hyperliquid for perp-futures trading.

Marcus Webb · 26 Sept 2026
Universal Corporation Highlights Tobacco Backbone and Ingredients Growth at Small-Cap Virtual Conference
CompaniesArticle

Universal Corporation Highlights Tobacco Backbone and Ingredients Growth at Small-Cap Virtual Conference

The company, trading near its 52‑week low with a 7.64% dividend yield, outlined its strategy to maximize tobacco cash flows while expanding its ingredients platform, which includes FruitSmart, Silva International and Shank’s Extracts, after more than $30 million in related investments.

Helena Vásquez · 26 Sept 2026
Prudential Financial Stock Drops to $20.1 as 52-Week Low
EquitiesArticle

Prudential Financial Stock Drops to $20.1 as 52-Week Low

The insurer’s shares fall 19.1% year-over-year amid sector-wide pressures and internal concerns.

Priya Anand · 26 Sept 2026
Atlassian speeds up US federal cloud authorization by six months
CompaniesArticle

Atlassian speeds up US federal cloud authorization by six months

Atlassian will submit its Impact Level 5 authorization request by July 2028, half a year ahead of schedule, as it pushes public-sector customers toward its cloud platform ahead of Data Center end-of-life.

Helena Vásquez · 26 Sept 2026
JBS Hits 52-Week Low as Trump Beef Order Weighs on Processor Stock
EquitiesArticle

JBS Hits 52-Week Low as Trump Beef Order Weighs on Processor Stock

JBS shares slumped to $11.48, down nearly 24% over the year, even as UBS raised its price target citing an improved earnings outlook and a buyout offer for Pilgrim's Pride.

Priya Anand · 26 Sept 2026
Columbus McKinnon Targets Debt Reduction Amid $2B Pro Forma Revenue Growth
M&AArticle

Columbus McKinnon Targets Debt Reduction Amid $2B Pro Forma Revenue Growth

The company aims to cut debt to below 4x leverage by 2028, while focusing on cost synergies and end-market demand shifts.

Lucas Ferreira · 26 Sept 2026
ADVERTISEMENT
Turkish Airlines orders up to 150 Boeing 737 MAX aircraft
EquitiesArticle

Turkish Airlines orders up to 150 Boeing 737 MAX aircraft

Turkish Airlines and Boeing have finalized an order for up to 150 Boeing 737 MAX aircraft, including a firm order for 100 737-8 aircraft and options for 50 additional 737 MAX jets. The agreement, concluded in New York on September 23, 2026, represents Turkish Airlines' largest single-aisle order to date.

Priya Anand · 26 Sept 2026
Acushnet Holdings Projects $220M–$230M 2026 Revenue Amid Tariff Adjustments
EquitiesArticle

Acushnet Holdings Projects $220M–$230M 2026 Revenue Amid Tariff Adjustments

Growth strategy, acquisitions and supply chain resilience drive small-cap first-aid and safety products leader.

Priya Anand · 26 Sept 2026
Escalade reports $240m 2025 sales, eyes double‑digit EBITDA margins
EarningsArticle

Escalade reports $240m 2025 sales, eyes double‑digit EBITDA margins

The small‑cap outdoor and sporting‑goods maker posted net sales of $240 million in 2025, net income of $13.7 million and a 26.9% net margin, while targeting 30% gross margins and debt‑free status by year‑end.

Priya Anand · 26 Sept 2026
Groupe Beneteau Reports H1 2026 Sales Growth, U.S. Losses Persist Amid Restructuring
EquitiesArticle

Groupe Beneteau Reports H1 2026 Sales Growth, U.S. Losses Persist Amid Restructuring

Sales surged by double digits in the first half of 2026, while U.S. operations remain loss-making as the company restructures its American operations.

Priya Anand · 26 Sept 2026
Newmark Stock Falls to 52-Week Low Despite Strong Second-Quarter Results
EquitiesArticle

Newmark Stock Falls to 52-Week Low Despite Strong Second-Quarter Results

Shares of the real estate services firm hit $13.35 even as Q2 revenue beat estimates and S&P upgraded its credit rating to investment grade.

Priya Anand · 26 Sept 2026
Nextpower Highlights Strong Demand, $5.5B Backlog at BNP Paribas Energy Conference
CompaniesArticle

Nextpower Highlights Strong Demand, $5.5B Backlog at BNP Paribas Energy Conference

Solar and storage developer Nextpower reported a $5.5 billion backlog and robust project pipeline at the BNP Paribas Power Up conference, as U.S. electricity demand is projected to grow 12-19% over the next five years.

Helena Vásquez · 26 Sept 2026
ADVERTISEMENT
← NewerPage 2 of 892Older →